Age-dependent accumulation of mitochondrial tRNA mutations in mouse kidneys linked to mitochondrial kidney diseases
- PMID: 40579478
- DOI: 10.1038/s43587-025-00909-y
Age-dependent accumulation of mitochondrial tRNA mutations in mouse kidneys linked to mitochondrial kidney diseases
Abstract
Heteroplasmic pathogenic mitochondrial DNA (mtDNA) mutations are key drivers of mitochondrial diseases, yet their tissue-specific and cell-specific accumulation patterns during aging and the mechanistic links to pathology remain poorly understood. In this study, we employed DddA-derived cytosine base editor technology to generate three mouse models harboring distinct pathogenic mitochondrial tRNA mutations. These mutations exhibited age-dependent accumulation in the kidneys, leading to severe kidney defects that well recapitulate human mitochondrial kidney disease. Mitochondrial single-cell assay for transposase-accessible chromatin with sequencing (mtscATAC-seq) revealed unique heteroplasmy dynamics across different kidney cell types: podocytes exhibited a positive selection for mutant mtDNA, whereas tubular epithelial cells displayed neutral drift of mutations during aging. Integrative analyses combining mtscATAC-seq, single-cell RNA sequencing and spatially enhanced resolution omics sequencing further identified molecular changes in high-mutant defective cells, including increased AP-1 family transcription factor activity, tubular epithelial cell proliferation and immune activation, which contribute to disease progression. Our study underscores the importance of kidney function monitoring in patients with mitochondrial disease, particularly in older adults, and establishes robust preclinical models to facilitate the development of therapeutic strategies.
© 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Similar articles
-
Unraveling bidirectional evolution of unstable mitochondrial DNA mutations in hepatocellular carcinoma at single-cell resolution.Hepatology. 2025 Jul 1;82(1):59-76. doi: 10.1097/HEP.0000000000001113. Epub 2024 Oct 11. Hepatology. 2025. PMID: 39641629
-
Correction of pathogenic mitochondrial DNA in patient-derived disease models using mitochondrial base editors.PLoS Biol. 2025 Jun 24;23(6):e3003207. doi: 10.1371/journal.pbio.3003207. eCollection 2025 Jun. PLoS Biol. 2025. PMID: 40554457 Free PMC article.
-
Chimeric mitochondrial RNA transcripts predict mitochondrial genome deletion mutations in mitochondrial genetic diseases and aging.Genome Res. 2025 Jan 22;35(1):55-65. doi: 10.1101/gr.279072.124. Genome Res. 2025. PMID: 39603705 Free PMC article.
-
PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring.Hum Reprod Update. 2012 Jul;18(4):341-9. doi: 10.1093/humupd/dms008. Epub 2012 Mar 28. Hum Reprod Update. 2012. PMID: 22456975
-
Understanding the impact of mitochondrial DNA mutations on aging and carcinogenesis (Review).Int J Mol Med. 2025 Aug;56(2):118. doi: 10.3892/ijmm.2025.5559. Epub 2025 Jun 6. Int J Mol Med. 2025. PMID: 40476552 Free PMC article. Review.
Cited by
-
Aging influences protein digestion, absorption and amino acid metabolism.Biogerontology. 2025 Jul 19;26(4):146. doi: 10.1007/s10522-025-10289-w. Biogerontology. 2025. PMID: 40682691 Review.
References
-
- Gustafsson, C. M., Falkenberg, M. & Larsson, N.-G. Maintenance and expression of mammalian mitochondrial DNA. Annu. Rev. Biochem. 85, 133–160 (2016). - PubMed
-
- Yarham, J. W., Elson, J. L., Blakely, E. L., McFarland, R. & Taylor, R. W. Mitochondrial tRNA mutations and disease. Wiley Interdiscip. Rev. RNA 1, 304–324 (2010). - PubMed
-
- Kazuhito, T. & Wei, F.-Y. Posttranscriptional modifications in mitochondrial tRNA and its implication in mitochondrial translation and disease. J. Biochem. 168, 435–444 (2020). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical